UK TRADING UPDATE SUMMARY: Caffyns To Reopen Showrooms As Curbs Ease
UK TRADING UPDATE SUMMARY: Caffyns To Reopen Showrooms As Curbs Ease
Read moreFri, 30th Oct 2015 08:09
UK TRADING UPDATE SUMMARY: Caffyns To Reopen Showrooms As Curbs Ease
Read more(Sharecast News) - Inhalation contract manufacturer Vectura Group noted an announcement from Novartis on Friday, that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the approval of 'Enerzair Breezhaler'.
Read moreUK BROKER RATINGS SUMMARY: Barclays Raises Pearson, Moneysupermarket
Read moreVectura Resilient Against Covid-19 As Flutiform Drives Annual Growth
Read moreUK Earnings, Trading Statements Calendar - Next 7 Days
Read moreUK BROKER RATINGS SUMMARY: Peel Hunt Cuts Ashtead And Raises DCC
Read moreAvacta Group Hires Vectura Group CFO Fry As Non-Executive Director
Read moreVectura Targeting New Royalties In 2020 As Glaxo Lawsuit Rumbles On
Read more(Sharecast News) - Pharmaceuticals company Vectura said on Monday that its base business had continued to perform well in 2019.
Read moreTOP NEWS: Hikma Submits Response To Advair Application Deficiencies
Read moreVectura Group Hires Former GE Healthcare Exec Will Downie As New CEO
Read more(Adds comment from GSK spokesman)Oct 4 (Reuters) - Vectura Group said on Friday a British court had ruled in its favour on the packaging of a generic version of an inhaler made by bigger rival GlaxoSmithKline.Vectura said the court dismissed all G...
Read moreHigh Court Dismisses Glaxo Case Against Generic Seretide Accuhaler
Read more